420 with CNW — NIDA Seeks Help in Creating Nationwide Registry of Medical Cannabis Use

By the end of last year, more than 30 states had launched some kind of medical cannabis market. But with each state independently passing its own policies, this has led to a patchwork of different medical cannabis legislation across the country. Last week, a top federal agency revealed that it plans on creating a countrywide medical cannabis registry that would allow it to study how patients use medical marijuana.

The National Institute on Drug Abuse (NIDA) has pledged to provide funding worth $1.5 million to researchers to help them develop a nationwide medical cannabis registry capable of tracking how medical cannabis patients in all legal states obtain and use medical cannabis as well as their medical outcomes. As NIDA stated in its request for applications (RFA), three-quarters of the states in the country have legalized medical cannabis, although each state has varying conditions regarding qualifying medical conditions and the types of medical marijuana products patients are allowed to use.

This patchwork landscape makes it extremely difficult for the agency to analyze medical cannabis use and how it is impacting the public. The information that is available is not standardized and cannot be used to understand the broader health outcomes associated with medical cannabis use, the agency explained.

NIDA also noted that there is little standardized information regarding the medical marijuana products being used because of lax laws surrounding labeling. As such, the agency will need to collect all the relevant information on medical cannabis products.

This registry will allow NIDA to study how different medical cannabis products affect patients and obtain a clearer idea of potential risks and benefits. According to the agency’s request for applications, the objective of this new information-gathering process is to find out which medical marijuana products are being used, the reasons why they are being used and the outcomes of use.

The agency is looking for a wide dataset from the medical cannabis industry that includes cannabis strains, cannabis forms, delivery methods, most prevalent cannabinoids, medical marijuana card status and the symptoms being addressed by medical cannabis treatment. NIDA is also interested in information pertaining to changes in other pharmaceutical and illicit drug use after the onset of medical marijuana treatment, as well as interactions between cannabis and other drugs.

Researchers who would like to take part in creating the registry and keeping it up to date can begin submitting applications on Oct. 15, 2022. They will be allowed to send in their applications for NIDA funding until Nov. 16, 2022.

These moves by federal agencies such as NIDA offer a ray of hope that real reforms may not be far off and industry actors, such as Flora Growth Corp. (NASDAQ: FLGC), may finally have a framework within which to operate nationally.

NOTE TO INVESTORS: The latest news and updates relating to Flora Growth Corp. (NASDAQ: FLGC) are available in the company’s newsroom at https://cnw.fm/FLGC

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — Colorado Study Finds Teen Cannabis Use Reduced Massively in 2021

A recent study of Colorado’s marijuana industry has revealed a fact that has been consistent in other states with legal cannabis markets: teen cannabis use is on the decline. Prohibitionists across the country had argued that legalizing adult-use cannabis would make the controversial drug more accessible and lead to increased drug use by the youth.

However, several studies have found that legalization has actually had the opposite effect, limiting youth access and reducing the number of young teens who consume cannabis. According to the recent Colorado study, 2021 saw an especially “dramatic” drop in cannabis use by teens. Dubbed the Healthy Kids Colorado Survey, the biennial state poll was carried out by the Colorado Department of Public Health and Environment (CDPHE).

The agency found that young teens were 35% less likely to consume cannabis in 2021 compared to previous years. This is reflective of several prior studies that have contradicted prohibitionists’ claims that legalizing cannabis would have an adverse effect on the country’s youth.  However, we should note that the coronavirus pandemic may have played a part in reducing youth cannabis use by keeping potential users in socially isolated conditions.

Either way, it is clear that cannabis reform policies have made it at least a little harder for students to access cannabis. According to the CDPHE’s new study, slightly more than 13% of the surveyed teens said they had consumed cannabis within the past 30 days compared to 20% back in 2013 when the agency first launched the Healthy Kids Colorado Survey.

NORML deputy director Paul Armentano says the Colorado study is consistent with the growing body of literature showing that it is entirely possible to launch a controlled recreational cannabis market for adults aged 21 and older while limiting access to underage individuals.

The 2021 study also revealed that more othan 40% of students found it easy to access cannabis when they were so inclined compared to almost 55% in 2013, a year before the state legalized cannabis and launched a controlled market. Furthermore, more than 60% of the respondents associated cannabis use with “moderate or great risk of harm,” compared to 54% in 2013.

This signifies a shift in how teens see cannabis and its perceived risks and benefits. Prohibitionists had feared that legalizing cannabis would cause youngsters to view it as completely safe, but the study shows youth aren’t looking at cannabis use through rose-tinted glasses.

Senator John Hickenlooper, formerly the governor of Colorado, was not a fan of legalization because he believed that it would encourage drug abuse among the state’s youth. More than a decade later, however, he acknowledges that his fears were unfounded and cannabis youth use is actually declining. He also praises the state’s cannabis industry, stating that legislators “created a good framework” that has been copied by several other states.

The findings of this Colorado study provide further proof that it wasn’t a mistake to open legal marijuana markets in which entities such as Cannabis Strategic Ventures Inc. (OTC: NUGS) can operate.

NOTE TO INVESTORS: The latest news and updates relating to Cannabis Strategic Ventures Inc. (OTC: NUGS) are available in the company’s newsroom at http://cnw.fm/NUGS

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Prime Harvest Inc.’s Jaxx Carving out Top Spot in Cannabis World

Prime Harvest’s Jaxx Cannabis is poised in the cannabis world with its outstanding, renowned customer service and quality products. “The flagship brand in a portfolio of superior offerings from Prime Harvest, Jaxx features an expertly curated selection of premium products from some of the most respected brands in the thriving California market. Jaxx products are carefully selected to combine value and quality to create an experience focused and centered on consumers… Visitors to both brick-and-mortar and online stores can choose from an array of categories, including flower, pre-rolls, vaporizers, concentrated, edibles, tinctures, and topicals. Jaxx enthusiasts can even order from a complete line of accessories, including everything from bowls and spoons to entire starter kits, as well as Jaxx swag, including t-shirts, hats and consumption accessories. Committed to empowering and changing lives, Jaxx excels at helping consumers find the right products for their unique lifestyles,” a recent article reads. “Jaxx places customers at the front and center… From the moment a potential customer steps inside the Jaxx world to the moment a consumer starts enjoying the cannabis experience they were looking for, Jaxx offers unparalleled support, assistance and service every step of the way.”

To view the full article, visit https://cnw.fm/AWad2

About Prime Harvest Inc.

Prime Harvest is a technology-focused full-service cannabis corporation. The company is horizontally diversified across various segments of the cannabis value chain, including licensing acquisition and compliance management, and state-wide direct-to-consumer operations. Based in the innovation hotspot of San Diego, California, Prime Harvest is expanding its footprint throughout the Golden State by executing a long-term strategy of investing in the growth and scale of licensed assets anchored by the power of data-driven technology. Prime Harvest’s flagship retail brand, Jaxx Cannabis, upholds exceptional standards of quality and services and provides a rewarding experience for customers in San Diego and the surrounding Southern California communities. Trust and credibility are at the heart of everything that the team at Prime Harvest stands for. The Prime Harvest team is composed of true experts in their respective fields, carefully assembled with the aim of building a world-class organization that can drive the cannabis industry and movement forward. For more information about the company, visit www.PrimeHarvestInc.com.

NOTE TO INVESTORS: The latest news and updates relating to Prime Harvest are available in the company’s newsroom at https://cnw.fm/PRIME

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “Cannabis” to 844-397-5787 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

Flora Growth Corp. (NASDAQ: FLGC) Authorizes the Repurchase of up to $5 Million Shares

  • Flora Growth Corp. announced that the Company Board has authorized the repurchase of up to $5 million of its outstanding common shares
  • Luis Merchan, Flora’s Chairman and CEO, said that Flora is executing its growth plans while simultaneously improving gross profit margins and reducing corporate overhead expenses
  • At the closing of 2021, the company announced a 2022 revenue guidance projection of $35-45 million

Flora Growth (NASDAQ: FLGC) is a global leader in the cultivation, marketing, and distribution of premium-quality cannabis products and brands at below-market prices. Flora Growth recently announced that the company’s Board of Directors (the “Board”) has authorized the repurchase of up to $5 million of its outstanding common shares subject to market conditions and the company’s liquidity warrant (https://cnw.fm/9m47y).

Luis Merchan, Flora’s Chairman and CEO, stated that the potential to repurchase their shares at these levels represents a compelling opportunity to deploy available cash to drive shareholder value. The company’s board believes that the decline in the market price of shares is due to the generally weak financial market and cannabis sector. It is also attributed to the recent selling of several millions of shares by certain shareholders who acquired such shares at a very low-cost basis, prior the company’s had its IPO, and who had previously been subject to a one-year lockup period which expired in mid-May.

Repurchases may be made from time to time through open market purchases, and, in no event shall the company repurchase more than five percent of the total number of issued and outstanding shares as of the repurchase date.

Flora’s 249-acre cultivation facility Cosechemos, based in Colombia, is the core of the company’s business model. The ideal location, resources, and climatic conditions at the Cosechemos farm, enable Flora’s low production cost which is approximately $0.06/gram, compared to production costs that can be as high as $1/gram or more in parts of North America (https://cnw.fm/gptGk).

On Feb 22, 2022, Columbia’s President Duque approved a previously announced legislation expanding on Resolution 811.  The new Resolution 227 allows the industrial use of cannabis in sectors such as food, beverages and textile. This new regulation will further pave way for increased revenues for the company (https://cnw.fm/WfqLT). Recently, Flora also solidified its foothold in the U.S., by acquiring the luxury cannabis consumer brand Vessel Brand Inc. 

For more information, visit the company’s website at www.FloraGrowth.com.

NOTE TO INVESTORS: The latest news and updates relating to FLGC are available in the company’s newsroom at https://cnw.fm/FLGC

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

Sugarmade Inc. (SGMD) Announces First Transaction Under Cannabis Global Inc. Contract

  • SGMD will produce an estimated 25,000 pounds of Fresh Frozen cannabis, which Cannabis Global will use in its product lines
  • The market for Fresh Frozen cannabis is “snowballing,” says Cannabis Global CEO
  • With the rapid Fresh Frozen harvesting process, airtight storage and near cryogenic storage temperatures, almost all of the natural cannabis plant essence is preserved

Sugarmade (OTC: SGMD), an emerging leader in the licensed cannabis sector, is seeing the fruit of its labors, so to speak. The company recently announced the first transaction under its previously announced contract with Cannabis Global (OTC: CBGL). The transaction calls for Sugarmade to produce an estimated 25,000 pounds of Fresh Frozen cannabis, which Cannabis Global will use in its product lines and will distribute to the California marketplace (https://cnw.fm/srEmn).

Sugarmade and Cannabis Global have signed a prebooked, fixed-price contract in the amount of $700,000; that payment includes cash payments from Cannabis Global to Sugarmade of $300,000 and notes for the balance of $400,000. Planting of the cultivators began in mid-May and will continue into early June.

“The market for Fresh Frozen cannabis is snowballing,” said Cannabis Global CEO Arman Tabatabaei. “Thus we believe it is the place to be for the 2022 cultivation season. We plan to process a large portion of the 25,000 pounds of ultra-premium cannabis at our Lynwood, California, laboratory, creating premium solventless extracts for sale into the market and for use in our own manufactured products, thus creating vertical integration to reduce our costs of goods sold. 

“We also plan to store a significant portion of the biomass in the Los Angeles area to create an active wholesale market to the many new solventless extractors in the area via our wholly owned distribution company, Northern Lights Distribution,” Tabatabaei continued. “We have integrated this cultivation effort into our strategic plan for 2022 and 2023b as an important component to further boost our already fast-growing revenue base.”

Fresh Frozen cannabis is flash frozen immediately after harvest instead of undergoing the traditional treatment of drying and curing. A growing number of cannabis consumers are choosing this type of cannabis as they seek naturally produced cannabis products full of natural plant terpenes and flavors. As demand grows, the number of products available that contain Fresh Frozen cannabis is also growing. 

“In many ways, the advent of Fresh Frozen-oriented cannabis cultivation has turned the cannabis cultivation model on its head,” a recent article observed. “Where cultivators traditionally harvested cannabis plants and then spent weeks or months drying, curing and processing plant materials, all the while battling heat, humidity, molds and other factors that could affect the product. 

“Fresh Frozen-oriented cultivation allows growers to ditch the traditional model by cutting down the plants at the peak of freshness, stripping the large leaves, branches and stems and then bagging the remaining materials bound for storage in industrial freezers at temperatures well below -5 F,” the article continued. “With the rapid harvesting process, airtight storage and near cryogenic storage temperatures, almost all of the natural cannabis plant essence is preserved.”

Sugarmade is a product and branding marketing company investing in operations and technologies with disruptive potential. The company’s brand portfolio includes CarryOutsupplies.com, SugarRush, NUG Avenue and Lemon Glow. 

For more information, visit the company’s website at www.Sugarmade.com

NOTE TO INVESTORS: The latest news and updates relating to SGMD are available in the company’s newsroom at http://cnw.fm/SGMD

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW — Brazilian Superior Court Authorizes Home Cultivation of Marijuana for Medical Use

The wave of cannabis reform that began rocking the world when jurisdictions within the United States and countries such as Uruguay and Canada legalized marijuana in various forms has now arrived in Brazil. Earlier this week, a top Brazilian court gave a trio of patients authorization to grow their own cannabis at home for medical treatment. Although the country’s health ministry still hasn’t issued regulations for at-home cultivation of cannabis, this ruling may set a precedent that could be applied across the country.

A panel of five judges from the Brazil Superior Court of Justice all agreed that the medical marijuana patients in question should be allowed to grow marijuana at home and extract its oil to use as a pain medication. According to Judge Rogério Schietti, the government’s failure to issue scientific guidelines on the issue forced the panel’s hand. He called most of the arguments against cannabis reform “moralistic,” arguing that they tended to have a religious nature and were based on false truths and stigmas.

This sense of moralism has delayed the development of legislation to regulate at-home cultivation and clouded the minds of local judges. He emphasized that the country needed to end this prejudice against marijuana and take a scientific position on cannabis reform, not a religious one.

Judge Antonio Saldanha, another member of the panel, added that the government’s delay in issuing guidelines for at-home cultivation of medical cannabis was a conscious “backward step to obscurantism.” The country’s main health body, the Brazilian Agency Regulatory Agency (ANVISA), has denied requests to allow home cultivation on a number of occasions.

Two years ago, Daniel Law and the Cannigma reported that ANVISA had begun authorizing the import, manufacture and sale of cannabis-based medications as well as the commercialization of medical as well as recreational marijuana.  However, this seems to go against Brazilian law, which only allows imported cannabis products for medical use.

By law, only three companies are authorized to grow, harvest and handle medical marijuana. These companies include the Cannabis and Health Association, the Brazilian Cannabis Support Association Esperança and the Support for Medical Cannabis Research and Patients.

Last year, the country’s far-right president, Jair Bolsonaro, declared that he did not support any efforts to authorize home cultivation of cannabis, even if it was for medical purposes. This is despite the fact that a prior survey from the International Drug Policy Consortium found that more than one-half (57%) of Brazilians were in favor of legalizing cannabis.

The authorization of cannabis home-grows for the patients who petitioned the court may open a deluge of interested parties that wish to leverage modern cannabis growing technologies and opportunities such as the grow pods sold by Advanced Container Technologies Inc. (OTC: ACTX).

NOTE TO INVESTORS: The latest news and updates relating to Advanced Container Technologies Inc. (OTC: ACTX) are available in the company’s newsroom at https://cnw.fm/ACTX

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — Top White House Drug Chief Says Feds are Reviewing Cannabis Policies

President Joe Biden based his campaign on renewable energy, infrastructure and cannabis decriminalization. Months after he assumed office, President Biden was working on a massive infrastructure bill that would invest hundreds of millions of dollars in the transition to cleaner energy sources. On the other hand, he hasn’t made any efforts to keep his cannabis campaign promises in the year and a half since he was inaugurated as the 46th president of the United States.

However, the word from a high-level White House official is that Biden’s administration is “monitoring” states with legal cannabis markets to help inform federal cannabis policy. The director of the Office of National Drug Control Policy (ONDCP) said in an interview with the Financial Times that the administration is currently learning from states that have already passed some kind of cannabis reform.

He stated that officials were looking into broad harm-reduction proposals, including supervised drug consumption sites for people suffering from addiction and even federal decriminalization. Gupta also said that Biden had made it clear that current marijuana policies were far from effective.

Gupta noted that this will be the first time America’s federal government is espousing harm-reduction policies rather than a prohibitionist approach. He emphasized that people shouldn’t be arrested or incarcerated for drug use, especially when people of color are several times more likely to be arrested and charged for drug use despite near-identical use rates with white people.

Even if the Biden administration doesn’t pass comprehensive cannabis reform, putting an end to drug-related arrests and incarcerations would basically amount to decriminalization from a policy perspective. Biden himself has stated that he does not support comprehensive reform or launching a recreational cannabis market at the federal level. Rather, he believes in passing medical marijuana legislation and letting individual states figure out how they want to regulate cannabis on their own.

One of the harm-reduction policies that are under review is the controversial safe consumption sites that would allow people who are currently addicted to illegal drugs to gain increased access to addiction treatment resources, hopefully reducing the number of overdose deaths.

Gupta says that the administration already has a proposal that would lift the ban on safe-consumption sites even though the efficiency of such centers is still in question. Officials from America’s first authorized harm reduction centers in New York City say the centers have been quite effective and are already saving lives.

As the federal administration warms up to the idea of legalizing or at least decriminalizing marijuana production, possession and consumption, the market served by licensed entities such as American Cannabis Partners is likely to explode nationwide.

NOTE TO INVESTORS: The latest news and updates relating to American Cannabis Partners are available in the company’s newsroom at https://cnw.fm/ACP

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

Advanced Container Technologies Inc. (ACTX) GrowPods Have Potential to Help Millions Living in Food-Insecure Households

  • Tens of millions of adults, children are living in food-insecure households
  • Micro-farms, such as ACTX’s Grow Pods, are being evaluated as a potential solution for food insecurity
  • With GrowPods, cultivation can be moved directly into the areas where food is needed

An estimated 30 million adults and 12 million children are living in food-insecure households, reports a recent CNN Business article (https://cnw.fm/o1wn5). Those are people that Advanced Container Technologies (OTC: ACTX), the exclusive U.S. distributor of Grow Pods, believes it can help.

“Families across America are precariously perched on the edge of a hunger cliff,” reports CNN Business. “With inflation on the rise and supply chain backlogs, more families have been turning to food banks, forcing programs nationwide to ration supplies and cut services. And now the war in Ukraine is leading to more food shortages and driving up prices even further. Now is not the time to turn our backs on those who cannot afford to put food on the table.

“The U.S. Department of Agriculture (‘USDA’) has estimated that as many as 30 million adults and 12 million children are living in food-insecure households,” the CNN report continued. “And the U.S. Census Bureau’s Household Pulse Survey found that in the last seven days, 10.3% of respondents sometimes or often did not have enough to eat. Local food aid organizations are essential community resources for families during this crisis, but they cannot do it all by themselves.”

Micro-farms, such as ACTX’s Grow Pods, are being evaluated as a potential solution for food insecurity. Last year, Virginia State University (“VSU”) was given a $600,000 grant to explore micro farms as a potential solution to what the school called “food deserts in urban neighborhoods” (https://cnw.fm/oGUed). According to the school, the grant will build VSU’s capacity to provide comprehensive education on micro farming.

Leonard Githinji, project director and sustainable and urban agriculture Cooperative Extension specialist at VSU, reports that more than 11% of the nation’s population and 10% of Virginia’s population are food insecure. “Residents in food-insecure areas, commonly known as food deserts, have little or no access to fresh, affordable and nutritious food, and often have higher instances of chronic diseases, such as obesity, due to poor diets,” Githinji states. “Developing sustainable micro farms in urban areas can have a profound impact on access to healthy food in food deserts.”

The funding will enhance VSU’s capacity to study micro farming and provide experiential learning and hands-on training to students, extension agents, master gardeners and youth leaders. Companies operating in the micro-farming space, such as Advanced Container Technologies, will also likely benefit from the study results. The three-year study will focus on developing and optimizing environmental growing conditions so that research-based information can be disseminated on best practices for micro farming.

ACTX is confident its GrowPods — modular hydroponic greenhouses — could become a valuable tool in efforts to combat food insecurity. “With GrowPods, cultivation can be moved directly into the areas where food is needed,” the company noted (https://cnw.fm/Fwx5Y). “Additionally, locating the pods nearer to the point of consumption allows food to be harvested at its peak nutritional value, and greatly reduces the carbon and environmental impact of the nation’s current food chain, which relies on trucks carrying mass quantities of produce across the country.”

GrowPods offer a controlled environment with major advantages for the production of high-value crops. The ability to grow crops year-round while cultivating in a smaller footprint using less resources make the systems particularly well suited for programs such as the LFPA. ACTX is the exclusive distributor of GrowPods in certain markets. The company also provides a variety of other products and services, including packaging solutions for medicinal, pharmaceutical, and agricultural products.

For more information, visit the company’s website at www.AdvancedContainerTechnologies.com.

NOTE TO INVESTORS: The latest news and updates relating to ACTX are available in the company’s newsroom at https://cnw.fm/ACTX

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

Lexaria Bioscience Corp. (NASDAQ: LEXX) Grants Licenses to Three Companies for the Month of June; Looks to Follow Through with its Scheduled 2022 Clinical Studies

  • Lexaria sold Premier Wellness Science Co. exclusive rights to use its patented DehyraTECH(TM) in Japan in a variety of CBD products
  • Valcon Medical A/S also signed an agreement with Lexaria to use its platform for medical cannabis applications in Europew
  • AnodGen Bioceuticals received a pharmaceutical license to use the platform for manufacturing and distributing CBD API powders in Europe, Australia, and New Zealand

Lexaria Bioscience (NASDAQ: LEXX) kicked off the month by announcing an exclusive license to Premier Wellness Science Co. for the use of its patented DehydraTECH(TM) technology in Japan in a variety of CBD products. Announced on June 3, this license would cover oral or non-liquid products and can be used in topical, hair-care, lip-care, and cosmetics segments. 

Premier is a wholesale and retail marketer of cosmetics and health foods in Japan. It also provides information and consulting services to entities in the anti-aging, beauty, and health industries. In addition, Premier also offers market research, data collection, and analysis for its clients. The arrangement with Lexaria includes minimum payments of $4.5 million to be paid over the first five years of the deal to maintain exclusivity, with the first payments being made beginning September 1, 2022.

On June 2, 2022, Lexaria announced having signed an agreement granting Valcon Medical A/S rights to use the DehydraTECH platform for medical cannabis applications in Europe. The products subject to this license were classified as non-registered medical products and authorized through country-level programs or EU Commission-registered cannabis products.

Valcon plans to use this platform in bulk powders, solid oral dosage forms, powder-filled capsules, compressed tablets, pills, oral melts, and topical creams and lotions. This non-exclusive license will attract milestone fees from Valcon upon completing batch validation and marketing authorization application approvals. Valcon is a European CMO that is good manufacturing practice (“GMP”) certified. It is licensed in Denmark to manufacture medical cannabis and works with partners to provide contract processing and bulk extract services.

On June 8, 2021, Lexaria announced having granted a pharmaceutical license for using its DehydraTECH platform to AnodGen Bioceuticals. AnodGen, a contract manufacturing organization (“CMO”), manufactures and distributes active pharmaceutical ingredients for the pharmaceutical industry by focusing on plant-based medicine. 

With Lexaria’s license, AnodGen will manufacture and distribute cannabidiol (“CBD”) active pharmaceutical ingredient (“API”) powders in Europe, Australia, and New Zealand. The license covers both pharmaceutical and medical product applications for psychoactive cannabinoids and medical applications for non-psychoactive cannabinoids. In addition, it can also be extended to third-party companies to use in their products.

Lexaria is confident that with these newly awarded licenses and ongoing research in hypertension and nicotine, it is preparing for increased global utilization of its technology and for increased cashflows in its journey towards profitability.

In an interview with Unboxing Biotech (https://cnw.fm/ocMfu) Chris Bunka, Lexaria’s CEO, shared his optimism for the company. In addition, he highlighted the company’s progress and the strides it would make as time progresses. More specifically, he acknowledged the advancement made so far regarding DehydraTECH and potential hypertension treatment, along with the company tapping into the nicotine replacement therapy (“NRT”) market.

Lexaria held its 2022 annual meeting on May 31, 2022. One of the key agendas in the meeting was the appointment of directors and an auditor for the current and future financial years. In the meeting represented by approximately half of all shareholders shares, all the nominated directors and auditor Davidson & Company LLP were approved. This would set the stage for Lexaria’s material partnerships that would define the month of June, as described in a recent Zacks report and interview covering Lexaria (https://cnw.fm/7mOLv).

Going forward, Lexaria looks to follow through with its clinical studies, advance its research and forge even more partnerships with other key players in the CBD space. In addition, the company looks to leverage its unique value proposition to grow its revenue and create value for its shareholders.

For more information, visit the company’s website at www.LexariaBioscience.com.

NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://cnw.fm/LEXX

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW — FDA Examines Possibility of Regulating CBD Products as Supplements

In the years since the 2018 farm bill legalized industrial hemp and hemp extracts such as cannabidiol (CBD), the CBD industry has grown into a behemoth. However, the U.S. Food and Drug Administration (FDA) has consistently failed to provide regulations for the industry, allowing it to become a barely regulated space that has been called the Wild West.

After years of relatively little action, regulators are finally taking a look into the cannabinoid market, specifically cannabinoid-infused dietary supplements. Last week, the FDA’s Science Board embarked on an all-day review to discuss specific, complex scientific and technical issues important to the agency and its mission.

Ideally, these discussions would pave the way for crafting suitable regulations for America’s billion-dollar CBD market. But after years of the agency dragging its feet, industry stakeholders have little hope that the review will lead to tangible CBD regulations that would allow businesses to sell CBD-infused dietary supplements.

Missouri-based CBD manufacturer and retailer Vince Sanders says it’s difficult to get excited about the review. He attended the FDA’s first cannabidiol hearing in 2019 in Maryland and has witnessed the agency’s inaction around CBD firsthand. Even more, the FDA’s hearing notice didn’t specifically mention CBD.

The meeting involved external drug safety and nutrition experts who had an informational discussion about the challenges faced in evaluating food ingredients that have some kind of pharmaceutical application, such as CBD, and used cannabinoids as a case study.

Cannabidiol is an active ingredient in an FDA-approved drug called epidiolex that is used to treat seizures in children suffering from Dravet syndrome and Lennox-Gastaut syndrome. Outside of approving the CBD-based drug for medical use, the FDA has done little else to regulate CBD, especially in the dietary and wellness segments.  The agency has also stated that it cannot regulate CBD in a nonpharmaceutical setting since it is an active ingredient in an approved prescription drug.

Although the notice didn’t mention CB, some cannabidiol producers have submitted comments to the agency. They hope the FDA will finally acknowledge the fact that the CBD industry is growing exponentially and desperately needs standardized regulations.

The director of regulatory affairs and quality assurance at Vantage Hemp Laura Eder says that players in the cannabis industry either regulate themselves via Good Manufacturing Practices (GMPs) or operate with complete impunity. Studies have found that a significant percentage of CBD products are either mislabeled or contaminated with fungus, bacteria, pesticides and heavy metals.

Some companies have also taken to making absurd and untrue claims about the medical abilities of their products. In recent years, the FDA’s only action regarding the CBD market has been to send such companies warning letters instructing them to desist from making such claims.

The entire cannabis industry, including companies such as Cannabis Strategic Ventures Inc. (OTC: NUGS), would appreciate comprehensive regulatory guidance regarding CBD products so that proper decisions can be made as to how to proceed in this segment.

NOTE TO INVESTORS: The latest news and updates relating to Cannabis Strategic Ventures Inc. (OTC: NUGS) are available in the company’s newsroom at http://cnw.fm/NUGS

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.